Yoo Byung-chul, advisor to the second chairman of the Korea Foundation...Best practice of social responsibility
Mar 05, 2025
Yoo Byung-chul, an advisory professor, will take office as the second chairman of the Korea Foundation.
After graduating from Seoul Medical University, Yoo Byung-chul served as a professor in the field of liver disease at Chung-Ang Medical University, Sungkyunkwan Medical University, and Konkuk Medical University, contributing greatly to the research and development of liver disease, and served as the chairman of the Korean Liver Association, devoted himself to the development of hepatology and public health.
Chairman Yoo Byung-chul said, `To ensure continuous development and leap forward in the future, the Korean Foundation will do its best to support the Korean Liver Association's research activities and international academic exchange projects and to fulfill its social responsibilities such as public relations, education, and medical policy establishment advice.'
Meanwhile, the Korea Liver Foundation was established in 2011 by the Korean Liver Association, which has been striving to realize the purpose and social mission of preventing and treating liver diseases and enlightening the general public.
Since its establishment in 2011, under the dedication and leadership of first chairman Seo Dong-jin, it has been evaluated that it has contributed greatly to the development of the hepatology field and the promotion of public health through research funding for liver disease researchers, public relations projects related to liver disease, and annual commemorative events after the establishment of liver day.
In particular, the Korean Liver Association and the Korea Liver Foundation have drastically lowered the prevalence of hepatitis B through active prevention of hepatitis B, suppressing the progression to cirrhosis and liver cancer through active antiviral treatment, and taking the lead in conquering liver cancer through early detection of liver cancer and introduction and research of various and active treatment techniques. In addition, it has achieved a high survival rate in the field of liver transplantation and is achieving world-class results.
The international status of the Korean Liver Association can be directly seen through the official journal Clinical and Molecular Hepaticology (CMH), which currently ranks sixth among 143 SCIE journals in the field of gastrointestinal and hepatic studies worldwide with an Impact Factor of 14.0.
After graduating from Seoul Medical University, Yoo Byung-chul served as a professor in the field of liver disease at Chung-Ang Medical University, Sungkyunkwan Medical University, and Konkuk Medical University, contributing greatly to the research and development of liver disease, and served as the chairman of the Korean Liver Association, devoted himself to the development of hepatology and public health.
Chairman Yoo Byung-chul said, `To ensure continuous development and leap forward in the future, the Korean Foundation will do its best to support the Korean Liver Association's research activities and international academic exchange projects and to fulfill its social responsibilities such as public relations, education, and medical policy establishment advice.'
Meanwhile, the Korea Liver Foundation was established in 2011 by the Korean Liver Association, which has been striving to realize the purpose and social mission of preventing and treating liver diseases and enlightening the general public.
Since its establishment in 2011, under the dedication and leadership of first chairman Seo Dong-jin, it has been evaluated that it has contributed greatly to the development of the hepatology field and the promotion of public health through research funding for liver disease researchers, public relations projects related to liver disease, and annual commemorative events after the establishment of liver day.
In particular, the Korean Liver Association and the Korea Liver Foundation have drastically lowered the prevalence of hepatitis B through active prevention of hepatitis B, suppressing the progression to cirrhosis and liver cancer through active antiviral treatment, and taking the lead in conquering liver cancer through early detection of liver cancer and introduction and research of various and active treatment techniques. In addition, it has achieved a high survival rate in the field of liver transplantation and is achieving world-class results.
The international status of the Korean Liver Association can be directly seen through the official journal Clinical and Molecular Hepaticology (CMH), which currently ranks sixth among 143 SCIE journals in the field of gastrointestinal and hepatic studies worldwide with an Impact Factor of 14.0.
|
This article was translated by Naver AI translator.
